Deep Medicine Acquisition (Deep Medicine Acquisition) PB Ratio : (As of Jun. 12, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Deep Medicine Acquisition PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-12), Deep Medicine Acquisition's share price is $3.20. Deep Medicine Acquisition's Book Value per Share for the quarter that ended in Sep. 2023 was $-0.21. Hence, Deep Medicine Acquisition's PB Ratio of today is .

The historical rank and industry rank for Deep Medicine Acquisition's PB Ratio or its related term are showing as below:

During the past 3 years, Deep Medicine Acquisition's highest PB Ratio was 27.27. The lowest was 0.00. And the median was 0.00.

DMAQ's PB Ratio is not ranked ^*
in the Diversified Financial Services industry.
Industry Median: 1.83
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Deep Medicine Acquisition's average Book Value Per Share Growth Rate was -102.70% per year.

Back to Basics: PB Ratio

Deep Medicine Acquisition PB Ratio Historical Data

The historical data trend for Deep Medicine Acquisition's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deep Medicine Acquisition PB Ratio Chart

Deep Medicine Acquisition Annual Data

Trend

Mar21

Mar22

Mar23

PB Ratio

1.31

19.17

Deep Medicine Acquisition Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
PB Ratio	Get a 7-Day Free Trial							1.34	15.26	19.17	22.88	-

Competitive Comparison of Deep Medicine Acquisition's PB Ratio

For the Shell Companies subindustry, Deep Medicine Acquisition's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Deep Medicine Acquisition's PB Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Deep Medicine Acquisition's PB Ratio distribution charts can be found below:

* The bar in red indicates where Deep Medicine Acquisition's PB Ratio falls into.

Deep Medicine Acquisition PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Deep Medicine Acquisition's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Sep. 2023)
	=	3.20	/	-0.205
	=

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Deep Medicine Acquisition (NAS:DMAQ) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Deep Medicine Acquisition PB Ratio Related Terms

Thank you for viewing the detailed overview of Deep Medicine Acquisition's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Deep Medicine Acquisition (Deep Medicine Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Deep Medicine Acquisition Corp (NAS:DMAQ) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

595 Madison Avenue, 12th Floor, New York, NY, USA, 10017

Website

Deep Medicine Acquisition Corp is a blank check company.

Executives

John Chiang	director	3538 TORRANCE BLVD., UNIT 177, TORRANCE CA 90503
Bryant Fong	director	2170 VALLEJO STREET #101, SAN FRANCISCO CA 94123
Humphrey P Polanen	director, officer: Chief Executive Officer	C/O HERITAGE COMMERCE CORP, 150 ALMADEN BLVD, SAN JOSE CA 95113
Weixuan Luo	officer: Chief Financial Officer	40 WALL STREET, 29TH FLOOR, NEW YORK NY 10005
Marc Hamer	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Bright Vision Sponsor Llc	10 percent owner	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Ronald M. Razmi	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Hongliang Ren	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Wanlei Miao	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017
Tina Spires	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017